Mira Pharmaceuticals (MIRA) Change in Cash (2022 - 2025)

Mira Pharmaceuticals (MIRA) has 4 years of Change in Cash data on file, last reported at $3.7 million in Q4 2025.

• Quarterly Change in Cash rose 382.5% year-over-year to $3.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (up 298.57% YoY) and the FY2025 annual result came in at $3.5 million, up 298.57% from the prior year.
• Change in Cash grew to $3.7 million in Q4 2025 per MIRA's latest filing, from $1.9 million in the prior quarter.
• The five-year high for Change in Cash was $5.8 million in Q3 2023, with the low at -$1.6 million in Q1 2025.
• Average Change in Cash over 4 years is $394352.7, with a median of -$412719.5 recorded in 2023.
• Year-over-year, Change in Cash surged 1015.1% in 2023 and tumbled 3102.96% in 2024.
• Mira Pharmaceuticals' Change in Cash stood at $163563.0 in 2022, then sank by 873.87% to -$1.3 million in 2023, then retreated by 3.62% to -$1.3 million in 2024, then surged by 382.5% to $3.7 million in 2025.
• Business Quant data shows MIRA's Change in Cash at $3.7 million in Q4 2025, $1.9 million in Q3 2025, and -$475810.0 in Q2 2025.